FDA authorizes first 2-in-1 wearable of its kind for patients with diabetes

The FDA has authorized the first 2-in-1 wearable device designed for diabetes patients, marking a new milestone in medical wearable technology. While this represents important progress in healthcare monitoring, it also raises questions for families who are already concerned about radiofrequency exposure from the growing number of wireless devices we wear and use daily.

Another Wireless Device to Consider

Medical wearables like this diabetes monitor typically use Bluetooth or similar wireless technology to transmit health data continuously. For parents already mindful of EMF exposure in their homes—whether from WiFi routers, smart devices, or cell towers—adding another body-worn transmitter is worth careful consideration, especially for children or family members who may need continuous glucose monitoring.

The challenge is real: these devices can provide life-saving health monitoring, but they also add to our total daily EMF exposure. This is the same balancing act many health-conscious families face when choosing between convenience and caution with everyday items, from selecting low-EMF hair dryers to evaluating air purifiers with minimal electromagnetic emissions.

What Health-Conscious Families Can Do

If you or a family member needs medical wearables, there are still steps you can take to minimize overall EMF exposure in your home. Consider reducing wireless emissions from other sources: use wired internet connections where possible, turn off WiFi at night, and create low-EMF zones in bedrooms. Some families even use EMF shielding paint in sleeping areas to reduce exposure from external sources like nearby cell towers.

The key is informed decision-making. Medical devices that improve health outcomes may be non-negotiable, but you can still control the electromagnetic environment in other areas of your life. Distance matters too—when devices must transmit wirelessly, keeping them away from the body when not in active use can reduce exposure.

Originally reported by Cardiovascular Business